Table 1b.
Correlation and association between muscle telomere length and cardiometabolic risk factors
| n | Partial correlation coefficient (95%; CI) p-value |
Regression coefficient (95%; CI)1 p-value |
|
|---|---|---|---|
| Age (years) | 58 | 0.03 (-0.23; 0.29) 0.84 |
0.001 (-0.009; 0.010) 0.83 |
| BMI (kg/m2) | 58 | -0.12 (-0.37; 0.14) 0.38 |
-0.60 (-1.74; 0.55) 0.30 |
| Fasting glucose (mmol/l) | 58 | 0.20 (-0.06; 0.43) 0.15 |
0.10 (-0.04; 0.24) 0.15 |
| 2h-glucose (mmol/l) | 58 | 0.03 (-0.23; 0.29) 0.84 |
0.05 (-0.35; 0.46) 0.79 |
| Fasting insulin (mU/l) | 57 | 0.05 (-0.21, 0.31) 0.72 |
-0.18 (-1.25; 0.89) 0.74 |
Multivariate linear regression with each cardiometabolic risk factor as the outcome and muscle telomere length (z-score) as the main exposure, adjusting for age, sex, diabetes family history and study. The estimates for age are from a model where telomere length was the outcome and age (z-score) the main exposure, adjusting for sex, diabetes family history and study